The Scientist

» patent and microbiology

Most Recent

image: Decoding Drug-Resistant TB

Decoding Drug-Resistant TB

By | September 1, 2013

Researchers characterize drug-resistant tuberculosis by analyzing the genomes of more than 500 Mycobacterium tuberculosis isolates from around the world.

0 Comments

image: Week in Review: August 19–23

Week in Review: August 19–23

By | August 23, 2013

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

0 Comments

image: Opinion: AIA Does Not Discriminate

Opinion: AIA Does Not Discriminate

By | August 21, 2013

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

5 Comments

image: Eat Less and Live Longer?

Eat Less and Live Longer?

By | August 13, 2013

Mice on a low-calorie diet harbor a distinct population of gut microorganisms that helps prolong life.

5 Comments

image: Opinion: Racing Toward Invention

Opinion: Racing Toward Invention

By | July 23, 2013

A newly instated patent law discriminates against academics and small biotechs.

6 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Microbial Diversity

Microbial Diversity

By | July 14, 2013

By sequencing bacterial and archaeal genomes from single cells, scientists have filled in many uncharted branches of the tree of life.

2 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Gut Microbes for Life

Gut Microbes for Life

By | July 4, 2013

Most strains of gut microbes stay with us for decades, which may prove useful for tracking our health.

6 Comments

image: Dodgy Data Underpin Stem Cell Trial

Dodgy Data Underpin Stem Cell Trial

By | July 3, 2013

The patent application behind a controversial Italian treatment for neurodegenerative disease may contain duplicated images.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech